Skip to main content
. Author manuscript; available in PMC: 2019 Feb 15.
Published in final edited form as: Am J Cardiol. 2017 Nov 24;121(4):430–436. doi: 10.1016/j.amjcard.2017.11.017

Table 3.

Adjusted Risk Ratios for 6-Year Decrease* in hs-cTnT by Duration of Exposure to Lifestyle-Related Factors at Baseline and Follow-up Visits

Exposure variables at visits 2, 3, and 4 Adjusted Risk Ratio
n=3017, N=599)
Smoker§
Non-current smoker at 0/3 visits REF[1]
Non-current smoker at 1/3 visits 0.66 (0.39, 1.12)
Non-current smoker at 2/3 visits 0.82 (0.52, 1.31)
Non-current smoker at 3/3 visits 0.73 (0.56, 0.96)
p-trend 0.06
Alcohol Drinker
Moderate drinker at 0/3 visits REF[1]
Moderate drinker at 1/3 visits 1.05 (0.81, 1.36)
Moderate drinker at 2/3 visits 1.20 (0.93, 1.55)
Moderate drinker at 3/3 visits 1.01 (0.81, 1.27)
p-trend 0.73
Body Mass Index
Non-obese at 0/3 visits REF[1]
Non-obese at 1/3 visits 1.35 (0.97, 1.88)
Non-obese at 2/3 visits 1.19 (0.80, 1.76)
Non-obese at 3/3 visits 1.45 (1.17, 1.80)
p-trend 0.001
Life’s Simple 7 Score
Average or Optimal LS7 at 0/3 visits REF[1]
Average or Optimal LS7 at 1/3 visits 1.96 (0.82, 4.66)
Average or Optimal LS7 at 2/3 visits 1.63 (0.72, 3.68)
Average or Optimal LS7 at 3/3 visits 2.64 (1.25, 5.58)
p-trend <0.001
*

Risk Ratio of Incident Undetectable Troponin (visit 4 hs-cTnT< 5ng/L) among those with detectable troponin (hs-cTnT≥ 5ng/L) at visit 2, compared to Sustained Detectable Troponin

Adjusted for Model 1: age, race-center, sex, education level, systolic blood pressure, diastolic blood pressure, antihypertensive medication use, total cholesterol, diabetes, eGFR, left ventricular hypertrophy

Adjusted for Model 2: age, race-center, sex, education level, eGFR, left ventricular hypertrophy

§

The reference category is current smoking at all 3 visits

The reference category is obese at all 3 visits